IPC use in non-malignant effusions

R. Davidson (Newcastle upon Tyne, United Kingdom), A. Aujayeb (Newcastle upon Tyne, United Kingdom), A. Aujayeb (newcastle, Mauritius)

Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Davidson (Newcastle upon Tyne, United Kingdom), A. Aujayeb (Newcastle upon Tyne, United Kingdom), A. Aujayeb (newcastle, Mauritius). IPC use in non-malignant effusions. 3137

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Usfulness of cholesterol in difering malignant and nonmalignant pleural effusions
Source: Eur Respir J 2004; 24: Suppl. 48, 246s
Year: 2004

Videothoracoscopy in the treatment of malignant pleural effusions
Source: Annual Congress 2009 - Pleural and mediastinal diseases
Year: 2009

The management of benign non-infective pleural effusions
Source: Eur Respir Rev 2016; 25: 303-316
Year: 2016



Separating malignant from nonmalignant pleural effusion on the basis of PO2 in pleural effusion
Source: Eur Respir J 2003; 22: Suppl. 45, 541s
Year: 2003

ERS/EACTS statement on the management of malignant pleural effusions
Source: Eur Respir J, 52 (1) 1800349; 10.1183/13993003.00349-2018
Year: 2018



ERS/EACTS statement on the management of malignant pleural effusions
Source: Guideline 2018
Year: 2018

Evaluation of concomitant pleural effusions in patients with lung cancers
Source: Eur Respir J 2007; 30: Suppl. 51, 668s
Year: 2007

Utility of LDH-A in the differentiation between lymphocytic pleural effusions of malignantand non-malignant etiology
Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside
Year: 2020


Comparison of telomerase activity in malignant and benign pleural effusions
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011

Management of malignant pleural effusions
Source: Eur Respir J 2001; 18: 402-419
Year: 2001


Management of malignant pleural effusions
Source: ERS Skills course: Multi-disciplinary care in thoracic oncology
Year: 2019

Management of malignant pleural effusions
Source: Guideline 2001
Year: 2001

Autofluorescence videothoracoscopy in exudative pleural effusions: preliminary results
Source: Eur Respir J 2005; 26: 989-992
Year: 2005



An update on treatment of malignant pleural effusion with or without known primary bronchial adenocarcinoma
Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis
Year: 2006


Are patients with malignant pleural effusions being referred appropriately for surgical intervention?
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008


Pleurodesis in the treatment of malignant pleural effusion
Source: Eur Respir J 2004; 24: Suppl. 48, 628s
Year: 2004

Management of recurrent malignant pleural effusions
Source: ERS Skills Course 2016 - Thoracoscopy and pleural techniques
Year: 2016

Management of recurrent malignant pleural effusions
Source: ERS Skills Course 2016
Year: 2016